Leukocytapheresis in the treatment of inflammatory bowel disease: Current position and perspectives

P Vernia, V D'Ovidio, D Meo - Transfusion and Apheresis Science, 2010 - Elsevier
Therapeutic apheresis, a novel approach for immunodisorders, has been used in the last
decade for the treatment of ulcerative colitis with promising result, and represents an …
被引用次数：18 相关文章

Leukocytapheresis in the treatment of inflammatory bowel disease: Current position and perspectives

P Vernia, V D'Ovidio, D Meo - Transfusion and Apheresis Science, 2010 - trasci.com
Therapeutic apheresis, a novel approach for immunodisorders, has been used in the last
decade for the treatment of ulcerative colitis with promising result, and represents an …

Leukocytapheresis in the treatment of inflammatory bowel disease: Current position and perspectives.

P Vernia, V D'Ovidio, D Meo - … Science: Official Journal of the World …, 2010 - europepmc.org
Therapeutic apheresis, a novel approach for immunodisorders, has been used in the last
decade for the treatment of ulcerative colitis with promising result, and represents an …

[引用][C] Leukocytaperesis in the treatment of inflamatory bowel diseas: current position and perspectives

P Vernia, V Dovidio, D Meo - TRANSFUSION AND APHERESIS …, 2010 - iris.uniroma1.it
Leukocytaperesis in the treatment of inflamatory bowel diseas: current position and perspectives
IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie IT Italiano …

Leukocytapheresis in the treatment of inflammatory bowel disease: Current position and perspectives

P Vernia, V D'Ovidio, D Meo - Transfusion and apheresis …, 2010 - pubmed.ncbi.nlm.nih.gov
Therapeutic apheresis, a novel approach for immunodisorders, has been used in the last
decade for the treatment of ulcerative colitis with promising result, and represents an …

Leukocytapheresis in the treatment of inflammatory bowel disease: Current position and perspectives

P Vernia, V D'Ovidio, D Meo - Transfusion and Apheresis Science, 2010 - infona.pl
Therapeutic apheresis, a novel approach for immunodisorders, has been used in the last
decade for the treatment of ulcerative colitis with promising result, and represents an …